Article: article from journal or magazin.
A mixed approach for proving non-inferiority in clinical trials with binary endpoints
When a new treatment is compared to an established one in a randomized clinical trial, it is standard practice to statistically test for non-inferiority rather than for superiority. When the endpoint is binary, one usually compares two treatments using either an odds-ratio or a difference of proportions. In this paper, we propose a mixed approach which uses both concepts. One first defines the non-inferiority margin using an odds-ratio and one ultimately proves non-inferiority statistically using a difference of proportions. The mixed approach is shown to be more powerful than the conventional odds-ratio approach when the efficacy of the established treatment is known (with good precision) and high (e.g. with more than 56% of success). The gain of power achieved may lead in turn to a substantial reduction in the sample size needed to prove non-inferiority. The mixed approach can be generalized to ordinal endpoints.
Anti-Bacterial Agents/therapeutic use, Clindamycin/therapeutic use, Data Interpretation, Statistical, Endpoint Determination, Female, Humans, Odds Ratio, Randomized Controlled Trials as Topic/methods, Sample Size, Therapeutic Equivalency, Vaginosis, Bacterial/drug therapy
Web of science
Last modification date